Related by context. Frequent words. (Click for all words.) 85 Phase III Clinical Trial 83 Phase III Trial 82 Pivotal Phase III 81 Patient Enrollment 80 Clinical Trial Results 80 Completes Enrollment 80 Pivotal Phase 76 Patients Treated 75 Clinical Study 75 Drug Candidate 75 Drug Eluting Stent 74 Monotherapy 74 FDA Accepts 73 Preclinical Data 73 Metastatic Colorectal Cancer 73 Presents Positive 73 Well Tolerated 73 Acute Myocardial Infarction 73 Drug Eluting Stents 72 Metastatic Melanoma 72 Coronary Stent 71 Multicenter 71 Overactive Bladder 71 Receives FDA Clearance 71 FDA Clearance 71 Pulmonary Arterial Hypertension 71 Bone Graft 71 Heart Failure Patients 71 Prostate Cancer Patients 70 Cardiac Resynchronization Therapy 70 phase IIb clinical 70 Clinical Trial 70 Elderly Patients 70 Dasatinib 70 FDA Clears 69 Generic Version 69 Initiates Phase 69 Chronic Heart Failure 69 Diabetic Macular Edema 69 Percutaneous Coronary Intervention 69 Low Dose 69 Pirfenidone 69 Stenting 69 Carotid 69 Cholesterol Drug 69 registrational trial 69 phase IIa 68 Study Demonstrates 68 Cethromycin 68 Chronic Hepatitis C 68 Advanced Prostate Cancer 68 Tesetaxel 68 Epratuzumab 68 Positive Opinion 68 Postmenopausal Women 68 Combination Therapy 68 Ofatumumab 68 Diabetic Patients 67 Thrombolysis 67 FDA Approves 67 Amrubicin 67 RNAi Therapeutics 67 Prostate Cancer Treatment 67 Stent System 67 Significantly Reduces 67 Tolerability 67 Phase Ib clinical 67 Phase 2b study 67 Ischemic 67 Non Invasive 67 k Clearance 67 placebo controlled Phase 67 phase IIb 67 Irinotecan 67 Chronic Lymphocytic Leukemia 67 Benign Prostatic Hyperplasia 66 Orphan Drug Status 66 MKC# 66 Panzem R 66 Peripheral Artery Disease 66 Fast Track Designation 66 Coronary Stent System 66 Icatibant 66 Monoclonal Antibody 66 Cardiovascular Events 66 Resection 66 Blood Thinner 66 Adalimumab 66 Enoxaparin 66 Marketing Authorization Application 66 Receives CE 65 Mipomersen 65 Breast Cancer Treatment 65 PRECISE 65 NYHA Class II 65 J Am Coll 65 FDA Orphan Drug 65 multicenter Phase 65 Fidaxomicin 65 FDA Approval 65 liposomal formulation